Life sciences news
-
OXURION confirms Institutional Review Board approval and submission of the Investigational New Drug Application to the FDA to start Phase 2 Study evaluating THR-687 for Diabetic Macular Edema (DME)
Thursday June 10th 2021
Read more
-
Biotalys nominates Catherine Moukheibir to its Board of Directors
Thursday June 10th 2021
Read more
-
argenx to regain global rights to cusatuzumab
Tuesday June 8th 2021
Read more
-
OXURION completes patient enrollment for Part A of Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)
Tuesday June 8th 2021
Read more
-
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Friday June 4th 2021
Read more
-
RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV
Wednesday June 2nd 2021
Read more
-
argenx appoints Karl Gubitz as Chief Financial Officer
Wednesday June 2nd 2021
Read more
-
Sequana Medical announces first patient enrolled in SAHARA DESERT
Tuesday June 1st 2021
Read more
-
Become a flanders.bio member
Your news here?
-
QbD Software announces major rebranding: Scilife is born
Thursday May 27th 2021
Read more
-
Nextstellis® receives FDA marketing exclusivity and phase III data published
Thursday May 27th 2021
Read more
-
Mithra announces European approval of Estelle®
Friday May 21st 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
